Trial Profile
Phase I-II Study Evaluating HSV-tK + VALACYCLOVIR GENE THERAPY Combination With Radiotherapy and Chemotherapy for Newly Diagnosed Anaplastic Astrocytoma and Glioblastoma Multiforme.
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 01 Sep 2023
Price :
$35
*
At a glance
- Drugs Aglatimagene besadenovec (Primary) ; Nalotimagene-carmaleucel (Primary) ; Valaciclovir (Primary)
- Indications Anaplastic astrocytoma; Glioblastoma
- Focus Therapeutic Use
- 31 Jul 2018 New trial record